Can escitalopram (Lexapro) cause hallucinations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Escitalopram and Hallucinations

Yes, escitalopram can cause hallucinations as a rare but serious adverse effect, particularly as part of serotonin syndrome or in vulnerable populations such as the elderly. This side effect requires immediate medical attention and possible discontinuation of the medication.

Mechanism and Risk Factors

Escitalopram, a selective serotonin reuptake inhibitor (SSRI), can potentially cause hallucinations through several mechanisms:

  • As part of serotonin syndrome, which includes mental status changes such as hallucinations, agitation, and delirium 1
  • Direct effects on serotonergic pathways in the brain
  • Age-related factors, particularly in elderly patients who may be more susceptible 2

Risk factors that increase the likelihood of experiencing hallucinations with escitalopram include:

  • Advanced age
  • Concomitant use of other serotonergic medications
  • History of psychiatric disorders
  • Renal or hepatic impairment

Clinical Presentation

Hallucinations associated with escitalopram may present as:

  • Visual hallucinations
  • Auditory hallucinations
  • Delusions
  • Other perceptual disturbances

These symptoms often occur in conjunction with other mental status changes such as:

  • Agitation
  • Confusion
  • Delirium
  • Anxiety
  • Emotional lability

Management Approach

When hallucinations occur in a patient taking escitalopram:

  1. Immediate assessment:

    • Evaluate for signs of serotonin syndrome (mental status changes, neuromuscular hyperactivity, autonomic instability)
    • Rule out other causes of hallucinations
  2. Medication management:

    • Consider discontinuation of escitalopram if hallucinations are severe or part of serotonin syndrome 1
    • Implement gradual dose reduction rather than abrupt cessation to minimize discontinuation symptoms 1
    • If serotonin syndrome is suspected, immediately discontinue escitalopram and any other serotonergic agents 1
  3. Treatment of hallucinations:

    • For severe cases, low-dose antipsychotics may be considered temporarily
    • Haloperidol (0.5-1 mg) or risperidone (0.25-0.5 mg) can be used for acute management 3
    • Avoid combining benzodiazepines with antipsychotics due to risk of oversedation 3
  4. Supportive care:

    • Monitor vital signs and mental status
    • Provide reassurance and orientation
    • Create a calm environment

Prevention and Monitoring

To prevent hallucinations and other serious adverse effects:

  • Start with lower doses in vulnerable populations (elderly, those with hepatic/renal impairment)
  • Avoid combining escitalopram with other serotonergic medications when possible
  • Monitor patients for early signs of mental status changes, particularly during treatment initiation or dose increases 4
  • Educate patients and caregivers about potential side effects and when to seek medical attention

Important Considerations

  • Hallucinations may be part of a broader serotonin syndrome, which is potentially life-threatening 1
  • Symptoms typically resolve after discontinuation of the medication 5, 2
  • Case reports have documented hallucinations and delusions occurring shortly after initiating SSRI treatment 5
  • While SSRIs like escitalopram are generally considered safe, they can still cause delirium and hallucinations, especially in elderly patients 2

If hallucinations occur, they should be taken seriously as they may indicate a significant adverse drug reaction requiring prompt medical intervention and possible medication adjustment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of High-Dose SSRI Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.